The most prevalent paediatric vision-threatening medical condition, retinoblastoma (RB),
has been a global concern for a long time. Several conventional therapies, such as systemic …

Retinoblastoma is a retinal cancer that affects children and is the most prevalent intraocular
tumor worldwide. Despite tremendous breakthroughs in our understanding of the …

ABSTRACT Introduction Retinoblastoma (Rb) is an early childhood intraocular tumor of the
retina and is managed by multimodal therapeutic approaches. Recent advanced targeted …

PURPOSE: To provide an overview of the current clinical management of retinoblastoma by
discussing the trends in the categorization, treatment, and recent advances in molecular …

Retinoblastoma (Rb) is a rare childhood intraocular malignancy with an incidence rate of
approximately 9000 children per year worldwide. The management of Rb is inherently …

With an average incidence of 1 in every 18,000 live births, retinoblastoma is a rare type of
intraocular tumour found to affect patients during their early childhood. It is curable if …

Retinoblastoma, the most common intraocular malignancy of childhood arises due to
mutation of the retinoblastoma gene on chromosome 13q14. In the hereditary setting this …

Retinoblastoma (Rb) is the most common pediatric ocular malignancy and accounts for 2%
of all childhood cancers. Rb is initiated by a mutation of the RB 1 tumor suppressor gene …

Retinoblastoma is a retinal cancer that is initiated in response to biallelic loss of RB1 in
almost all cases, together with other genetic/epigenetic changes culminating in the …

Retinoblastoma is a rare childhood cancer of the developing retina, and studies on this
orphan disease have led to fundamental discoveries in cancer biology. Retinoblastoma has …